Alex Renshaw
Orthopaedic Surgery · Phoenix, AZNPI 1790059814
Payments from drug & device makers
Across 89 payments — averaging $270.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- FX Shoulder Solutions, Inc$6K
- Goode Surgical Inc$5K
- Arthrex$5K
- CDC Medical LLC$4K
- Stryker$2K
- Globus Medical$1K
- plus $2K from 9 others
What the payments were for
- Consulting fees$5,78724%
- Travel & lodging$5,00421%
- Food & beverage$1,8698%
- Education$11,38847%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| FX Shoulder Solutions, Inc | 3 | $5,878 |
| Goode Surgical Inc | 5 | $5,046 |
| Arthrex | 21 | $4,631 |
| CDC Medical LLC | 17 | $4,215 |
| Stryker | 14 | $1,552 |
| Globus Medical | 5 | $1,117 |
| Medacta USA, Inc. | 4 | $767 |
| Smith+Nephew | 8 | $457 |
| Medtronic(2 entities) | 2 | $134 |
| Zimmer Biomet | 2 | $104 |
| Johnson & Johnson | 3 | $52 |
| Endo Pharmaceuticals Inc. | 2 | $33 |
| Orthofix Medical, Inc. | 1 | $26 |
| Curonix LLC | 1 | $23 |
| Convatec Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- HIP ARTHROSCOPY ACCESS & INSTRUMENTATION SET$1,128
- Joint Arthroplasty$566
- GMK SPHERE$496
- Onvoy$455
- AMISTEM$219
- CORI$209
- Journey Uni$209
- Journey II XR$209
- POLARSTEM$209
- OR3O$209
- REUNION$122
- KYPHON Balloon Kyphoplasty$121
How this compares
$24,049 in reported general payments places this provider in the 80th percentile of 377 orthopaedic surgery providers in Arizona.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Celecoxib | 39 | $1,403 |
| Ibuprofen | 76 | $451 |
| Methocarbamol | 73 | $398 |
| Oxycodone Hcl | 67 | $347 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 14 | $308 |
| Ondansetron Hcl | 25 | $303 |
| Gabapentin | 33 | $250 |
| Tramadol Hcl | 108 | $235 |
| Methylprednisolone | 19 | $90 |
| Cephalexin | 12 | $81 |
| Prednisone | 36 | $68 |
| Meloxicam | 13 | $12 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Phoenix
- Joseph GimbelPhoenix$19.4M
- Evan LedermanPhoenix$13.4M
- James ChowPhoenix$6.2M
- Michael McKeePhoenix$3.4M
- Henry ClarkePhoenix$1.9M
- Samuel HarmsenPhoenix$1.1M
- Maegen WallacePhoenix$832K
- Anthony HedleyPhoenix$417K
- Matthew SeidelPhoenix$397K
- David OttPhoenix$380K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.